Seroprevalence of Anaplasma phagocytophilum Antibodies Following Tick Bites: A Serosurvey in a Tertiary Care Hospital in Romania
Open Access
- 28 July 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (8) , 1758
Abstract
Human granulocytic anaplasmosis is an emerging tick-borne disease. Although Anaplasma phagocytophilum has been identified in vectors and animal reservoirs in Romania, evidence of human exposure has not yet been reported. This study aimed to generate initial evidence of human infection by evaluating A. phagocytophilum antibodies in individuals with recent tick exposure. We conducted a cross-sectional serosurvey between 2023 and 2024 at a tertiary care hospital in Bucharest, enrolling 80 participants 4 to 12 weeks following a tick bite. Serum IgG antibodies against A. phagocytophilum were detected using an indirect immunofluorescence assay, with a titer of ≥1:64 considered indicative of seropositivity. Eight (10%) participants tested positive for A. phagocytophilum IgG antibodies. Seropositivity was not significantly associated with demographics, geographical region, or clinical symptoms. However, fatigue and myalgia were more frequently seen in A. phagocytophilum IgG seropositive individuals. Notably, 43.8% of all participants reported erythema migrans, including five of the eight individuals with positive A. phagocytophilum IgG serology. This study provides the first serological evidence of human exposure to A. phagocytophilum in Romania. A 10% seroprevalence in this high-risk group suggests that anaplasmosis may be underrecognized. Clinicians should consider it in patients with tick exposure and compatible symptoms.Keywords
This publication has 24 references indexed in Scilit:
- Antibodies to Anaplasma phagocytophilum in Patients with Human Granulocytic Anaplasmosis Confirmed by Both Polymerase Chain Reaction and CultureThe American Journal of Medicine, 2024
- Worldwide meta-analysis on Anaplasma phagocytophilum infections in animal reservoirs: Prevalence, distribution and reservoir diversityVeterinary Parasitology: Regional Studies and Reports, 2022
- Anaplasma phagocytophilum infection rates in questing and host-attached ticks: a global systematic review and meta-analysisActa Tropica, 2022
- Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme DiseaseArthritis Care & Research, 2020
- To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosisClinical Microbiology and Infection, 2018
- The risk of exposure to rickettsial infections and human granulocytic anaplasmosis associated with Ixodes ricinus tick bites in humans in Romania: A multiannual studyTicks and Tick-borne Diseases, 2017
- Assessing the risk of human granulocytic anaplasmosis and lyme borreliosis after a tick bite in Bavaria, GermanyInternational Journal of Medical Microbiology, 2015
- Anaplasma phagocytophilum in questing Ixodes ricinus ticks from RomaniaTicks and Tick-borne Diseases, 2015
- Ixodes ricinus is the dominant questing tick in forest habitats in Romania: the results from a countrywide dragging campaignExperimental and Applied Acarology, 2012
- Serologic evidence of Anaplasma phagocytophilum infections in patients with a history of tick bite in central SlovakiaWiener klinische Wochenschrift, 2008